Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Medical Case Reports
Published in: Journal of Medical Case Reports 1/2021

01-12-2021 | Escherichia Coli | Case report

Septic shock due to Escherichia coli meningoencephalitis treated with immunoglobulin-M-enriched immunoglobulin preparation as adjuvant therapy: a case report

Authors: V. Pota, M. B. Passavanti, F. Coppolino, F. Di Zazzo, L. De Nardis, R. Esposito, M. Fiore, G. S. R. C. Mangoni di Santostefano, C. Aurilio, P. Sansone, M. C. Pace

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

Gram-negative bacteria are an uncommon etiology of spontaneous community-acquired adult meningitis and meningoencephalitis. Escherichia coli is a Gram-negative bacterium that is normally present in the intestinal microbial pool. Some Escherichia coli strains can cause diseases in humans and animals, with both intestinal and extraintestinal manifestations (extraintestinal pathogenic Escherichia coli) such as urinary tract infections, bacteremia with sepsis, and, more rarely, meningitis. Meningitis continues to be an important cause of mortality throughout the world, despite progress in antimicrobial chemotherapy and supportive therapy. The mortality rate fluctuates between 15% and 40%, and about 50% of the survivors report neurological sequelae. The majority of Escherichia coli meningitis cases develop as a result of hematogenous spread, with higher degrees of bacteremia also being related to worse prognosis. Cases presenting with impaired consciousness (that is, coma) are also reported to have poorer outcomes.

Case presentation

We describe the case of a 48-year-old caucasian woman with meningoencephalitis, with a marked alteration of consciousness on admission, and septic shock secondary to pyelonephritis caused by Escherichia coli, treated with targeted antimicrobial therapy and immunoglobulin-M-enriched immunoglobulin (Pentaglobin) preparation as adjuvant therapy.

Conclusion

Despite the dramatic presentation of the patient on admission, the conflicting data on the use of immunoglobulins in septic shock, and the lack of evidence regarding their use in adult Escherichia coli meningoencephalitis, we obtained a remarkable improvement of her clinical condition, accompanied by partial resolution of her neurological deficits.
Literature
1.
van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, Pfister HW, Read RC, Resat Sipahi O, Brouwer MC, For the ESCMID Study Group for Infections of the Brain (ESGIB). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22:S37–62.PubMedCrossRef
2.
Young N, Thomas M. Meningitis in adults: diagnosis and management. Intern Med J. 2018;48:1294–307.PubMedCrossRef
3.
Edmon K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317–28.CrossRef
4.
van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849–59.PubMedCrossRef
5.
Pomar V, Benito N, López-Contrera J, Coll P, Gurguí M, Domingo P. Spontaneous gram-negative bacillary meningitis in adult patients: characteristics and outcome. Infect Dis. 2013;13:451.
6.
Bichon A, Aubry C, Dubourg G, Drouet H, Lagier JC, Raoult D, Parola P. Escherichia coli spontaneous community-acquired meningitis in adults: a case report and literature review. Int J Infect Dis. 2018;67:70–4.PubMedCrossRef
7.
8.
9.
Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018;2018(44):925–8.CrossRef
10.
Rhodes A, Evans L, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–77.PubMedCrossRef
11.
Pota V, Passavanti MB, Sansone P, Pace MC, Peluso F, Fiorelli A, Aurilio C. Septic shock from descending necrotizing mediastinitis—combined treatment with IgM-enriched immunoglobulin preparation and direct polymyxin B hemoperfusion: a case report. J Med Case Rep. 2018;12:55.PubMedPubMedCentralCrossRef
12.
Kakoullis L, Pantzaris ND, Platanaki C, Lagadinou M, Papachristodoulou E, Velissaris D. The use of IgM-enriched immunoglobulin in adult patients with sepsis. J Crit Care. 2018;47:30–5.PubMedCrossRef
13.
Chang CJ, Chang WN, Huang LT, Huang SC, Chang YC, Hung PL, Lu CH, Chang CS, Cheng BC, Lee PY, Wang KW, Chang HW. Bacterial meningitis in infants: the epidemiology, clinical features, and prognostic factors. Brain Dev. 2004;26(3):168–75.PubMedCrossRef
14.
Mahjoub-Messai F, Bidet P, Caro V, Diancourt L, Biran V, Aujard Y, Bingen E, Bonacorsi S. Escherichiacoli isolates causing bacteremia via gut translocation and urinary tract infection in young infants exhibit different virulence genotypes. J Infect Dis. 2011;203(12):1844–9.PubMedCrossRef
15.
Iqbal J, Dufendach KR, Wellons JC, Kuba MG, Nickols HH, Gómez-Duarte OG, Wynn JL. Lethal neonatal meningoencephalitis caused by multi-drug resistant, highly virulent Escherichiacoli. Infect Dis. 2016;48(6):461–6.CrossRef
16.
Hsu MH, Hsu JF, Kuo HC, Lai MY, Chiang MC, Lin YJ, Huang HR, Chu SM, Tsai MH. Neurological complications in young infants with acute bacterial meningitis. Front Neurol. 2018;24(9):903.CrossRef
17.
18.
Kasimahanti R, Satish SK, Anand M. Community-acquired Escherichia coli meningitis with ventriculitis in an adult—a rare case report. J Intensive Care. 2018;24(6):63.CrossRef
19.
Huang CR, Lu CH, Chang WN. Adult Enterobacter meningitis: a high incidence of coinfection with other pathogens and frequent association with neurosurgical procedures. Infection. 2001;29:75–9.PubMedCrossRef
20.
Tosa M, Aihara M, Murakami J. Extended-spectrum beta-lactamase-producing Escherichiacoli meningitis that developed from otitis media with cholesteatoma. Intern Med. 2018;57(21):3199–204.PubMedPubMedCentralCrossRef
21.
Kim KS. Human meningitis-associated Escherichia coli. EcoSal Plus. 2016;7(1).
22.
Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, Choroszy-Krol I. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichiacoli isolated from different sources: recent reports. Gut Pathog. 2019;21(11):10.CrossRef
23.
Vibha D, Bhatia R, Prasad K, Srivastava MVP, Tripathi M, Singh MB. Clinical features and independent prognostic factors for acute bacterial meningitis in adults. Neurocrit Care. 2010;13:199–204.PubMedCrossRef
24.
Liu WT, Lv YJ, Yang RC, Fu JY, Liu L, Wang H, Cao Q, Tan C, Chen HC, Wang XR. New insights into meningitic Escherichiacoli infection of brain microvascular endothelial cells from quantitative proteomics analysis. J Neuroinflamm. 2018;15(1):291.CrossRef
25.
Al-Obaidi MMJ, Desa MNM. Mechanisms of blood brain barrier disruption by different types of bacteria, and bacterial-host interactions facilitate the bacterial pathogen invading the brain. Cell Mol Neurobiol. 2018;38(7):1349–68.PubMedCrossRef
26.
Gerber J, Nau R. Mechanisms of injury in bacterial meningitis. Curr Opin Neurol. 2010;23(3):312–8.PubMedCrossRef
27.
Neal JW, Gasque P. How does the brain limit the severity of inflammation and tissue injury during bacterial meningitis? J Neuropathol Exp Neurol. 2013;72(5):370–85.PubMedCrossRef
28.
Barichello T, Generoso JS, Simões LR, Goularte JA, Petronilho F, Saigal P, Badawy M, Quevedo J. Role of microglial activation in the pathophysiology of bacterial meningitis. Mol Neurobiol. 2016;53(3):1770–81.PubMedCrossRef
29.
Doran KS, Fulde M, Gratz N, Kim BJ, Nau R, Prasadarao N, Schubert-Unkmeir A, Tuomanen EI, Valentin-Weigand P. Host–pathogen interactions in bacterial meningitis. Acta Neuropathol. 2016;131(2):185–209.PubMedPubMedCentralCrossRef
30.
Thorsdottir S, Henriques-Normark B, Iovino F. The role of microglia in bacterial meningitis: inflammatory response, experimental models and new neuroprotective therapeutic strategies. Front Microbiol. 2019;10:576.PubMedPubMedCentralCrossRef
31.
Tauber SC, Eiffert H, Brück W, Nau R. Septic encephalopathy and septic encephalitis. Expert Rev Anti-infect Ther. 2017;15(2):121–32.PubMedCrossRef
32.
33.
34.
Lummel N, Koch M, Klein M, Pfister HW, Brückmann H, Linn J. Spectrum and prevalence of pathological intracranial magnetic resonance imaging findings in acute bacterial meningitis. Clin Neuroradiol. 2016;26(2):159–67.PubMedCrossRef
35.
36.
Hazany S, Go JL, Law M. Magnetic resonance imaging of infectious meningitis and ventriculitis in adults. Top Magn Reson Imaging. 2014;23(5):315–25.PubMedCrossRef
37.
Oliveira CR, Morriss MC, Mistrot JG, Cantey JB, Doern CD, Sánchez PJ. Brain magnetic resonance imaging of infants with bacterial meningitis. J Pediatr. 2014;165(1):134–9.PubMedPubMedCentralCrossRef
38.
Schibler M, Eperon G, Kenfak A, Lascano A, Vargas MI, Stahl JP. Diagnostic tools to tackle infectious causes of encephalitis and meningoencephalitis in immunocompetent adults in Europe. Clin Microbiol Infect. 2019;25:408–14.PubMedCrossRef
39.
Van Samkar A, Poulsen MNF, Bienfait HP, Van Leeuwen RB. Acute cerebellitis in adults: a case report and review of the literature. BMC Res Notes. 2017;10(1):610.PubMedPubMedCentralCrossRef
40.
Bertrand A, Leclercq D, Martinez-Almoyna L, Girard N, Stahl JP, De-Broucker T. MR imaging of adult acute infectious encephalitis. Med Mal Infect. 2017;47(3):195–205.PubMedCrossRef
41.
Cui J, Wei X, Lv H, Li Y, Li P, Chen Z, Liu G. The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis. Ann Intensive Care. 2019;9(1):27.PubMedPubMedCentralCrossRef
42.
Alejandria MM, Lansang MA, Dans LF, Mantaring JB 3rd. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. 2013;9:CD001090.
43.
Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007;35:2686–92.PubMed
44.
Pildal J, Gøtzsche PC. Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis. 2004;39:38–46.PubMedCrossRef
45.
Kreymann KG, de Heer G, Nierhaus A, et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med. 2007;35:2677–85.PubMed
46.
Shankar-Hari M, Culshaw N, Post B, et al. Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med. 2015;41:1393–2140.PubMedCrossRef
47.
Busani S, Damiani E, Cavazzuti I, Donati A, Girardis M. Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol. 2016;82(5):559–72.PubMed
48.
Matsuo H, Itoh H, Kitamura N, Kamikubo Y, Higuchi T, Shiga S, Ichiyama S, Kondo T, Takaori-Kondo A, Adachi S. Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria. Biochem Biophys Res Commun. 2015;464(1):94–9.PubMedCrossRef
49.
Berlot G, Vassallo MC, Busetto N, Nieto Yabar M, Istrati T, Baronio S, Quarantotto G, Bixio M, Barbati G, Dattola R, Longo I, Chillemi A, Scamperle A, Iscra F, Tomasini A. Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients. Ann Intensive Care. 2018;8(1):122.PubMedPubMedCentralCrossRef
Metadata
Title
Septic shock due to Escherichia coli meningoencephalitis treated with immunoglobulin-M-enriched immunoglobulin preparation as adjuvant therapy: a case report
Authors
V. Pota
M. B. Passavanti
F. Coppolino
F. Di Zazzo
L. De Nardis
R. Esposito
M. Fiore
G. S. R. C. Mangoni di Santostefano
C. Aurilio
P. Sansone
M. C. Pace
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-02731-7

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue

Correction

Correction to: Recurrent spontaneous abortion related to balanced translocation of chromosomes: two case reports

Case report

Sigmoid volvulus in pregnancy: a case report

Case report

Acute gastric dilatation in a patient with severe anorexia nervosa: a case report

Case report

Classic Kaposi sarcoma in a patient of Miao ethnicity followed up for 7 years: a case report

Case report

Uncertainty of leukoencephalopathies: a case report

Case report

Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report